YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)

Guidant Defibrillators


AddThis Social Bookmark Button

Guidant Defibrillators

On April 5, Boston Scientific/Guidant recalled approximately 73,000 Implantable Cardiac Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds). A faulty capacitor in these devices may cause the batteries to deplete sooner than expected. Most patients will not be affected by this recall, but patients with one of the recalled devices should contact their physicians about what steps to take next. Please see the questions below for additional information.

What exactly is affected by this Boston Scientific/Guidant recall?

The affected devices distributed in the US include the Contak Renewal 3 HE CRT-Ds (Models H177 and H179); Contak Renewal 3 CRT-Ds (Models H170 and H175); Vitality 2 DR ICDs (T165); Vitality 2 VR ICDs (T175); Vitality AVT ICDs (A155); Vitality DS DR ICDs (T125); and Vitality EL DR ICDs (T135).

What is the problem with these devices? A capacitor in the affected devices could malfunction, leading to premature battery depletion. How serious is this? As of March 30, 2007, Boston Scientific has confirmed 19 field events with Guidant’s devices, primarily related to premature battery depletion. There were no serious injuries or deaths reported.

On December 14, 2005 Guidant announced that 3 more patients with recalled defibrillators made by Guidant have died, bringing the total number of known deaths linked to the faulty products to seven. Guidant is under investigation by federal and state officials and faces dozens of lawsuits over its recalls. Guidant Corp. on October 14, 2005 told U.S. regulators that they received reports of 6 additional failures of implantable heart defibrillators since issuing a July notice about the devices used to regulate cardiac rhythms.

The failures were in the Contak Renewal and Renewal 2 models, the FDA said in an update posted 10/13/05 on the agency's website. The two devices were among models included in warnings Guidant sent to doctors in June, which the FDA classified July 1 as recalls. The new reports of failures bring the total worldwide to 21, including three cases in which patients died, Daniel Schultz, the director of the FDA's Center for Devices and Radiological Health, said.

Other News
Guidant Corp. has recalled several models of its cardiac defibrillators due to defects in the devices and numerous reports of device failure and death. The defibrillator recall and its follow-up advisory combined affect approximately 74,900 devices worldwide. The implantable cardioverter defibrillators, or ICDs, are intended to sense irregular heart rhythms and to send an electrical pulse to the heart to shock it into beating properly. The Guidant defibrillator defects include short circuiting, problems with the magnetic switch and computer memory problems. The defect that causes short circuiting of the device has caused two deaths to date, including the sudden death in March 2005 of a 21-year-old college student. Following are details of the models affected by the recall and the follow-up advisory:

2005 Recall
June 16, 2005 - Guidant recalled 50,000 defibrillator devices including the following models:
  • Prizm 2 DR, Model 1861, manufactured on or before April 16, 2002
  • Contak Renewal, Model H135, manufactured on or before Aug. 26, 2004
  • Contak Renewal 2, Model H155, manufactured on or before Aug. 26, 2004
  • Prizm AVT Vitality
  • Renewal 3 AVT
  • Renewal 4 AVT
June 24, 2005 - Guidant issued an advisory about additional defibrillator devices including the following models:
  • Contak Renewal 3 and 4
  • Renewal RF
Guidant claims that it discovered the short circuiting defect in 2002 and changed the manufacturing of the devices that year to correct the defect. However, Guidant continued to sell the old defective devices without notifying doctors that improved ones were available. Defibrillators cost approximately $25,000 apiece. Guidant’s 2004 defibrillator sales totaled $1.8 billion, signaling that until recently, Guidant may have been more motivated by profits than by patient safety.

Heart patients with a defibrillator who are unsure if their device is one of the malfunctioning models should contact their doctor as soon as possible to determine if their model requires replacement, if their device can be reprogrammed, or if their device is not affected by the recently announced safety issues.

2006 Recall
On June 26, 2006, the FDA and Guidant informed all patients and medical professionals that Guidant’s Ventak Prizm 2, Vitality and Vitality 2 Implantable Cardioverter Defibrillators have been associated with five reports of device malfunction due to the failure of a low-voltage capacitor from a single component supplier. Patients who have these particular ICD devices may experience inappropriate sensing or early battery depletion.

If you or a loved one suffered injuries from a Guidant Defibrillator, please fill out the form at the right for a free case evaluation by a qualified defective medical device attorney.
Guidant DefibrillatorsRSS Feed

Boston Scientific Agrees to Pay $22 Million to Settle Guidant Charges

Dec 29, 2009 | Parker Waichman Alonso LLP
For the second time in a month, Boston Scientific has settled federal charges related to Guidant Corporation.  Boston Scientific acquired Guidant in 2005.   Last month, the Boston Scientific agreed to pay $296 million to settle another Justice Department probe into Guidant’s handling of heart devices. According to a report in the Pioneer Press, this latest settlement involves allegations that Guidant designed four post-market studies in 2003 and 2004 as a means to increase...

Boston Scientific Settles Probe Over Defibrillators

Nov 9, 2009 | Parker Waichman Alonso LLP
Last year we wrote that a prominent physician from the Minneapolis Heart Institute Foundation had expressed concern about test guidelines for a next-generation heart defibrillator under development at the time by Medtronic, Inc., Boston Scientific Corporation, and St. Jude Medical, Inc. Now, Bloomberg News is reporting that Boston Scientific has agreed to pay nearly $300 million to settle an investigation conducted by the U.S. Justice Department on the medical device maker’s Guidant unit...

Boston Scientific Settles Probe Over Defibrillators

Jan 1, 2009
Last year we wrote that a prominent physician from the Minneapolis Heart Institute Foundation had expressed concern about test guidelines for a next-generation heart defibrillator under development at the time by Medtronic, Inc., Boston Scientific Corporation, and St. Jude Medical, Inc. Now, Bloomberg News is reporting that Boston Scientific has agreed to pay nearly $300 million to settle an investigation conducted by the U.S. Justice Department on the medical device maker’s Guidant unit...

Defective Guidant Defibrillators Maker Boston Scientific Agrees to Pay $195 mill

Jul 16, 2007 | Parker Waichman Alonso LLP
Boston Scientific, the maker of Defective Implantable Guidant Heart Defibrillators, will pay $195 million to settle thousands of lawsuits filed by patients who said they were never informed about potential flaws in the defibrillators.  The settlement includes around 4,000 claims brought by patients around the country that had been consolidated for trail at the US District Court in Minneapolis.  The trial was scheduled to begin on July 27.The lawsuits involved in the settlement are...

Boston Scientific recalls defibrillators

Apr 11, 2007 | www.bizjournals.com
Boston Scientific Corp. has recalled some of its defibrillators, the FDA confirmed on its website. A posting on the FDA's website detailed that on April 5, Natick, Mass.-based Boston Scientific recalled approximately 73,000 implantable cardiac defibrillators and cardiac resynchronization therapy defibrillators, due to a flaw in the devices that can cause the batteries to wear out sooner than expected. The company said that most patients would not be affected by the recall, but should contact...

More Guidant Defibrillators News

Guidant Defibrillators
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Which Guidant cardiac defibrillator was implanted?









If other, what is the name of the defibrillator that was implanted?

Date the device was implanted:

Is the device still implanted?


What medical condition prompted the use of the device?

Please describe any problems or injuries caused by the device:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Contact
Statement of Clients' Rights | Site Map | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Fusarium Keratitis | Stevens Johnson Syndrome

© 2002-2010 YourLawyer.com®. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising